105 related articles for article (PubMed ID: 19153736)
1. Indomethacin overcomes doxorubicin resistance by decreasing intracellular content of glutathione and its conjugates with decreasing expression of gamma-glutamylcysteine synthetase via promoter activity in doxorubicin-resistant leukemia cells.
Asano T; Tsutsuda-Asano A; Fukunaga Y
Cancer Chemother Pharmacol; 2009 Sep; 64(4):715-21. PubMed ID: 19153736
[TBL] [Abstract][Full Text] [Related]
2. Indomethacin overcomes doxorubicin resistance with inhibiting multi-drug resistance protein 1 (MRP1).
Matsunaga S; Asano T; Tsutsuda-Asano A; Fukunaga Y
Cancer Chemother Pharmacol; 2006 Sep; 58(3):348-53. PubMed ID: 16331495
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the regulatory subunit of gamma-glutamylcysteine synthetase in HeLa cells increases gamma-glutamylcysteine synthetase activity and confers drug resistance.
Tipnis SR; Blake DG; Shepherd AG; McLellan LI
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):559-66. PubMed ID: 9895302
[TBL] [Abstract][Full Text] [Related]
4. Redox-sensitive interaction between KIAA0132 and Nrf2 mediates indomethacin-induced expression of gamma-glutamylcysteine synthetase.
Sekhar KR; Spitz DR; Harris S; Nguyen TT; Meredith MJ; Holt JT; Gius D; Marnett LJ; Summar ML; Freeman ML
Free Radic Biol Med; 2002 Apr; 32(7):650-62. PubMed ID: 11909699
[TBL] [Abstract][Full Text] [Related]
5. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD
Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116
[TBL] [Abstract][Full Text] [Related]
6. Reversal effect of vitamin D on different multidrug-resistant cells.
Yan M; Nuriding H
Genet Mol Res; 2014 Aug; 13(3):6239-47. PubMed ID: 25158250
[TBL] [Abstract][Full Text] [Related]
7. Hammerhead ribozyme against gamma-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteins.
Iida T; Kijima H; Urata Y; Goto S; Ihara Y; Oka M; Kohno S; Scanlon KJ; Kondo T
Cancer Gene Ther; 2001 Oct; 8(10):803-14. PubMed ID: 11687904
[TBL] [Abstract][Full Text] [Related]
8. Indomethacin induces apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRP1.
de Groot DJ; van der Deen M; Le TK; Regeling A; de Jong S; de Vries EG
Br J Cancer; 2007 Oct; 97(8):1077-83. PubMed ID: 17940500
[TBL] [Abstract][Full Text] [Related]
9. Lack of correlation of MRP and gamma-glutamylcysteine synthetase overexpression with doxorubicin resistance due to increased apoptosis in SV40 large T-antigen-transformed human mesothelial cells.
Ogretmen B; Bahadori H; McCauley M; Boylan A; Green M; Safa AR
Cancer Chemother Pharmacol; 1998; 42(6):441-6. PubMed ID: 9788569
[TBL] [Abstract][Full Text] [Related]
10. Novel bicistronic retroviral vector expressing gamma-glutamylcysteine synthetase and the multidrug resistance protein 1 (MRP1) protects cells from MRP1-effluxed drugs and alkylating agents.
Rappa G; Lorico A; Hildinger M; Fodstad Ø; Baum C
Hum Gene Ther; 2001 Sep; 12(14):1785-96. PubMed ID: 11560771
[TBL] [Abstract][Full Text] [Related]
11. Flavonoids increase the intracellular glutathione level by transactivation of the gamma-glutamylcysteine synthetase catalytical subunit promoter.
Myhrstad MC; Carlsen H; Nordström O; Blomhoff R; Moskaug JØ
Free Radic Biol Med; 2002 Mar; 32(5):386-93. PubMed ID: 11864778
[TBL] [Abstract][Full Text] [Related]
12. Glycomic alterations are associated with multidrug resistance in human leukemia.
Zhang Z; Zhao Y; Jiang L; Miao X; Zhou H; Jia L
Int J Biochem Cell Biol; 2012 Aug; 44(8):1244-53. PubMed ID: 22579717
[TBL] [Abstract][Full Text] [Related]
13. Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines.
Yao KS; Godwin AK; Johnson SW; Ozols RF; O'Dwyer PJ; Hamilton TC
Cancer Res; 1995 Oct; 55(19):4367-74. PubMed ID: 7671249
[TBL] [Abstract][Full Text] [Related]
14. Ligustrazine derivate DLJ14 reduces multidrug resistance of K562/A02 cells by modulating GSTπ activity.
Song YN; Guo XL; Zheng BB; Liu XY; Dong X; Yu LG; Cheng YN
Toxicol In Vitro; 2011 Jun; 25(4):937-43. PubMed ID: 21402141
[TBL] [Abstract][Full Text] [Related]
15. B4GALT1 gene knockdown inhibits the hedgehog pathway and reverses multidrug resistance in the human leukemia K562/adriamycin-resistant cell line.
Zhou H; Zhang Z; Liu C; Jin C; Zhang J; Miao X; Jia L
IUBMB Life; 2012 Nov; 64(11):889-900. PubMed ID: 23024026
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells.
Xie P; Shen YF; Shi YP; Ge SM; Gu ZH; Wang J; Mu HJ; Zhang B; Qiao WZ; Xie KM
Leuk Res; 2008 Mar; 32(3):475-80. PubMed ID: 17709137
[TBL] [Abstract][Full Text] [Related]
17. Reversal of cisplatin and multidrug resistance by ribozyme-mediated glutathione suppression.
Nagata J; Kijima H; Hatanaka H; Asai S; Miyachi H; Takagi A; Miwa T; Mine T; Yamazaki H; Nakamura M; Kondo T; Scanlon KJ; Ueyama Y
Biochem Biophys Res Commun; 2001 Aug; 286(2):406-13. PubMed ID: 11500053
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of glutathione synthesis reverses Krüppel-like factor 4-mediated cisplatin resistance.
Jia Y; Zhang W; Liu H; Peng L; Yang Z; Lou J
Cancer Chemother Pharmacol; 2012 Feb; 69(2):377-85. PubMed ID: 21833590
[TBL] [Abstract][Full Text] [Related]
19. Reversal effects of droloxifene on multidrug resistance in adriamycin-resistant K562 cell line.
Li J; Xu LZ; Yao JJ; Guo WJ; Xia P; Chen Y
Acta Pharmacol Sin; 2001 Nov; 22(11):1023-7. PubMed ID: 11749795
[TBL] [Abstract][Full Text] [Related]
20. Increase in gamma-glutamylcysteine synthetase activity and steady-state messenger RNA levels in melphalan-resistant DU-145 human prostate carcinoma cells expressing elevated glutathione levels.
Bailey HH; Gipp JJ; Ripple M; Wilding G; Mulcahy RT
Cancer Res; 1992 Sep; 52(18):5115-8. PubMed ID: 1355406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
